Adult Community-Onset (CO) Sepsis Standardized Mortality Ratio (SMR)
| 2026 Reporting Period | |
| Quality Measure | Adult Community-Onset Sepsis Standardized Mortality Ratio (SMR) |
| NHSN Module | Sepsis Surveillance Module |
| NHSN Protocol | 2026 Sepsis Surveillance Module Protocol v1 (Coming soon) |
| NHSN Module Description | The Sepsis Surveillance Module provides a mechanism for automated reporting of Sepsis events as part of patient-safety and quality improvement efforts. It provides acute care hospitals with an approach for tracking a broad scope of sepsis events, leveraging Healthcare Level Seven International® (HL7®) Fast Healthcare Interoperability Resources® (FHIR®) to enable algorithmic determinations from clinical data available in electronic health records (EHRs). |
| Short Name | Sepsis SMR |
| CBE ID* | TBD |
| Measure Steward | CDC NHSN |
| Measure Description | Annual risk-adjusted standardized mortality ratio (SMR) of adult inpatients with community-onset sepsis. SMR is reported annually and is calculated by dividing the number of observed adult community-onset sepsis in-hospital deaths or discharges to hospice by the number of predicted community-onset sepsis in-hospital deaths or discharge to hospice. |
| Measure Scoring | Ratio |
| Measure Type | Outcome |
| Stratification | None |
| Risk Adjustment | The Risk Adjustment Model includes the following variables (organized by data source):
From Electronic Health Records, via Fast Healthcare Interoperability Resources:
From Claims (ICD-10)
From NHSN Annual Survey
|
| Rationale | The primary objective of this sepsis measure is to provide hospitals with actionable data on the incidence and outcomes of sepsis to drive improvements in patient care and patient safety. Sepsis remains a leading cause of morbidity, mortality, and healthcare resource utilization in hospitalized patients, with outcomes that are highly sensitive to the timeliness and reliability of recognition and treatment. Variation in sepsis identification and management practices across healthcare facilities contributes to preventable delays in care and differences in patient outcomes.
Routine measurement and monitoring of sepsis events enable healthcare facilities to better understand the incidence and impact of sepsis, evaluate adherence to evidence‑based practices, and identify gaps in care delivery. Tracking sepsis epidemiology and outcomes—including mortality, intensive care unit utilization, and length of hospital stay—provides critical insight into both clinical performance and system‑level processes. These data support the early identification of trends, facilitate targeted quality improvement initiatives, and allow hospitals to assess the effectiveness of sepsis screening, treatment pathways, and performance improvement programs over time. By promoting consistent surveillance, standardized management, and outcome measurement, this sepsis measure aligns with national and international guidance that emphasizes performance improvement, monitoring, and accountability as central components of effective hospital‑based sepsis programs. The use of actionable sepsis data supports continuous improvement efforts aimed at reducing sepsis‑associated mortality, improving care reliability, and optimizing patient outcomes. References:
|
| Clinical Recommendation Statement | Healthcare facilities should implement standardized processes for the prevention, early identification, timely treatment, and ongoing monitoring of sepsis events. Patients identified with suspected or confirmed sepsis during hospitalization should be managed using evidence‑based clinical pathways, with attention to timely recognition, prompt intervention, and continuous evaluation of clinical response and outcomes.
Recommendations:
References:
|
| Improvement Notation | A lower measure score indicates higher quality |
| Definition | ED/OBS encounter: Any patient visit to an emergency department (ED) or observation (OBS) location. One patient visit equals one encounter. ED/OBS are considered outpatient locations.
Hospital Stay: NHSN defines a hospital stay to be inclusive of any: (a) ED/OBS encounters, (b) inpatient admissions, or (c) ED/OBS encounters that lead to inpatient admissions (within 1 hour of ED/OBS encounters). Inpatient admission: For NHSN reporting purposes, the ‘date admitted to the facility’ is hospital day (HD) 1. NHSN defines an inpatient as any patient cared for or housed on an inpatient location. Local status may differ from NHSN definition; all days spent in an inpatient unit, regardless of local admission status and/or billing status are included in the counts of admissions and inpatient days. For NHSN reporting purposes, the date admitted to the facility is the calendar date that the patient physically locates to an inpatient location. Present on Admission (POA): Diagnosis that is present on the day of admission to an inpatient location (calendar day 1), the 2 days before admission, or the calendar day after admission (POA time period). Facility Days: Facility days are used to count days present at the facility during a hospital stay. The first day of a Hospital Stay is Facility Day 1. Measurement Period: Time period used for metric calculation CO Sepsis (COS): Community-Onset Sepsis HO Sepsis (HOS): Hospital-Onset Sepsis Inpatient Mortality: Patients who die during the hospital stay or are discharged to hospice. |
| Adult Sepsis Events are identified using a combination of clinical indicators of presumed serious infection and evidence of organ dysfunction documented during hospitalization. Indicators of presumed infection include the collection of blood cultures and the initiation of new antimicrobial therapy. Antimicrobial therapy should reflect the administration of systemic antibacterial or antifungal agents intended to treat suspected infection.
Evidence of organ dysfunction may include abnormalities in laboratory results, initiation of supportive therapies, or other indicators consistent with acute physiologic deterioration. Examples may include elevated serum lactate, abnormal renal or hepatic laboratory values, initiation of vasopressor therapy, or the initiation of mechanical ventilation. These indicators should be interpreted within the clinical context and in accordance with the Adult Sepsis Event surveillance definition. Timing relationships between infection indicators and organ dysfunction indicators are used to determine whether a qualifying Adult Sepsis Event has occurred. Event identification is based on the temporal association of these elements as documented in the electronic health record. Clinical, laboratory, and medication administration data used to identify Adult Sepsis Events should be available within the electronic health record and exposed using the FHIR Release 4 standard. Relevant data elements should be codified using HL7 standardized terminology to support consistent identification of eligible events across systems. This version of the measure uses the Acute Care Hospital (ACH) Monthly Reporting Profiles in the NHSN dQM Content Package IG. Please refer to the NHSN FHIR Portal for additional information on FHIR-based digital quality measures. |
|
| Initial Population | All encounters for patients of any age in an ED, observation, or inpatient location and/or all encounters for patients of any age with an ED, observation, inpatient, or short stay status that overlap the measurement period. |
| Denominator | Number of annually predicted adults with community- onset sepsis who died during hospitalization or were discharged to hospice. |
| Denominator Exclusions | None |
| Numerator | Number of annually observed adults with community- onset sepsis who died during hospitalization or were discharged to hospice. |
| Numerator Exclusions |
|
| Denominator Exceptions | None |
| Previous Version | None |